AstraZeneca
A Study Monitor at AstraZeneca's Safety Sciences China group supports the design, conduct, and reporting of non-clinical in vivo toxicology studies at Contract Research Organisations (CROs). The role involves collaborating with global colleagues and internal project teams to ensure high-quality regulatory data delivery for drug development and marketing authorisation. This position requires expertise in regulatory toxicology, study design, and cross-functional communication to mitigate safety risks across various therapeutic modalities.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
26% below the average for this role
Study Monitor - level D or E
ICON plc
Manager – In Vivo Toxicology (Home-Based, UK)
ICON plc
Associate Director, Study Operations Manager - Nonclinical Toxicology
Centessa Pharmaceuticals
Associate Director, Study Operations Manager - Nonclinical Toxicology
Jobgether
Senior Scientist, Study Toxicologist
Insmed Incorporated
Study Director
Altasciences